youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
DNA:NYSE
Ginkgo Bioworks Holdings Inc
$9.85
arrow_downward
-12.33%(-1.38) 1D
$9.88
arrow_upward
+0.30% (+0.030)bedtimeAfter hours
Closed: Nov 2, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
$11.35
High
$11.35
Low
$9.28
Mkt. cap
633.75M
Avg. vol.
3.34M
Volume
3.55M
52-wk high
$18.22
52-wk low
$5.37
EPS
-$5.00
Beta
1.79
Shares outstanding
55.38M
No. of employees
485
Open
$11.35
High
$11.35
Low
$9.28
Mkt. cap
633.75M
Avg. vol.
3.34M
Volume
3.55M
52-wk high
$18.22
52-wk low
$5.37
EPS
-$5.00
Beta
1.79
Shares outstanding
55.38M
No. of employees
485
News stories
From web sources and news partners
marketscreener.com
·
27 minutes ago
S&P 500 index fell sharply after Stockholm exchange close Monday
BigGo Finance
·
13 minutes ago
Nasdaq Vice Chairman Warns: Taiwan Stocks Climb to World's Fourth Largest, but 79% AI Exposure Tops the Globe
Quantisnow
·
50 minutes ago
Pershing Square USA, Ltd. Releases Third Quarter 2026 Portfolio Review
MarketWatch
·
8 hours ago
Nasdaq Inc. stock outperforms competitors on strong trading day
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees485
Founded2008
HeadquartersBoston, Massachusetts, United States
SectorHealth care
Websiteginkgo.bio